Persisters, relapse (Reactivation), drug resistance and multidrug therapy (MDT): Uniform diagnostic guidelines for leprosy are needed

Journal of Dermatology

Volumn 23, Issue 12, 1996, Pages 905-907

  Sehgal, Virendra N ^a   Jain, Sanjiv ^b   Charya, Sumit N Bhatta ^c  

^a Sehgal Nursing Home   (India)

^b Skin Care Clinic   (India)

^c UCMS AND GTB HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLOFAZIMINE; DAPSONE; LEPROSTATIC AGENT; MINOCYCLINE; OFLOXACIN; PEFLOXACIN; RIFABUTIN; RIFAMPICIN; RIFAPENTINE; ROXITHROMYCIN;

ANTIBIOTIC RESISTANCE; DIAGNOSTIC TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEPROSY; LETTER; MULTIDRUG RESISTANCE; MYCOBACTERIOSIS; MYCOBACTERIUM LEPRAE; NONHUMAN; PRACTICE GUIDELINE; RELAPSE; TREATMENT OUTCOME; VIRUS REACTIVATION;

EID: 0030445989     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1996.tb02725.x     Document Type: Letter

References (18)

1. Noordeen SK,: A look at world leprosy, Lepr Rev, 62: 72-86, 1991.
2. Anonymous: Chemotherapy of Leprosy for Control Programmes, Geneva: WHO Technical Report Series No. 675, 1982.
3. Anonymous: Epidemiology of Leprosy in Relation to Control, Geneva: WHO Technical Report Series No. 716, 1995.
4. Anonymous: WHO Expert Committee on Leprosy, Technical Report Series No. 768, 1988.
5. Sehgal VN,: Jogender: Slit-skin smear in leprosy, Int J Dermatol, 29: 9-16, 1990.
6. Noordeen SK, Lopez B, Sundaresan TK,: Estimated number of leprosy patients in the world, Lepr Rev, 63: 282-287, 1992.
7. Girdhar BK, Girdhar A, Chauhan SL, et al. Borderline tuberculoid relapse in lepromatous leprosy, Lepr Rev, 64: 157-163, 1993.
8. Saunderson PW,: Tuberculoid relapse in lepromatous leprosy, Lepr Rev, 64: 170-171, 1993.
9. Thomas A, Hari L, Nagarajan M, Prabhakar R,: Relapses during long-term follow-up with drug susceptible M. leprae among multibacillary leprosy patients, treated with multidrug therapy regimens case reports, Int J Lepr, 53: 391-394, 1995.
10. Katoch K, Ramanathan V, Natrajan M, et al. Relapse in paucibacillary patients after treatment with three short term regimens containing rifampin, Int J Lepr, 57: 458-464, 1989.
11. Chopra NK, Aggarwal JS, Padya PC,: A study of relapse in paucibacillary leprosy in a multidrug therapy project; Baroda district India, Lepr Rev, 61: 157-162, 1990.
12. Ganssen F, Wallach D, Khuong MA, et al. Association de maladie de Hansen et d'infection par le virusd immunodeficience humaine. Deux observation, Press Med, 17: 1652-1653, 1988.
13. Lucas S,: Human immunodeficiency virus and leprosy, Lepr Rev, 64: 97-103, 1993.
14. Sehgal VN, Bhattacharya SN, Jain S,: Relapse or late reversal reaction, Int J Lepr, 58: 118-120, 1990.
15. Sehgal VN,: Clinical Leprosy, 3rd ed, Jaypee Bros, New Delhi, 1993, pp 182-189.
16. Ji B, Grosset JH,: Recent advnces in the chemotherapy of leprosy (editorial), Lepr Rev, 61: 313-329, 1990.
17. Beckx BM,: Relapses among leprosy patients treated with multidrug therapy; Experience in the leprosy control program of the all Africa leprosy and rehabilitation training center (ALERT) in Ethiopia; Practical difficulties with diagnosing relapses; Operational procedures and criteria for diagnosing relapses, Int J Lepr, 60: 421-426, 1992.
18. Ji B, Jamet P, Perani EG, Bobin P, Grosset JH,: Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy, J Infect Dis, 168: 188-190, 1993.